Showing results (181-190 of 286) with videos related to

Sort By:
Pageof 29
Oncotarget|December 2, 2015
Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinomaHui-Wen Lue, Brook Cole, Soumya A M Rao, et al.
Transplantation|March 22, 2002
Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplantsSusan L Orloff, Daniel N Streblow, Cecilia Soderberg-Naucler, et al.
Cold Spring Harbor Molecular Case Studies|August 25, 2021
Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusionClare Keddy, Tanaya Neff, Jianya Huan, et al.
Patterns (New York, N.Y.)|June 28, 2021
Causal interactions from proteomic profiles: Molecular data meet pathway knowledgeÖzgün Babur, Augustin Luna, Anil Korkut, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
Genome-wide classification of tumor-derived reads from bulk long-read sequencingToby M Baker, Nedas Matulionis, Cassidy Andrasz, et al.
The Journal of Pathology|May 28, 2005
The gene expression profile of extraskeletal myxoid chondrosarcomaSubbaya Subramanian, Robert B West, Robert J Marinelli, et al.
Molecular Oncology|June 3, 2008
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expressionParaic A Kenny, Genee Y Lee, Connie A Myers, et al.
The American Journal of Pathology|June 25, 2004
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation statusRobert B West, Christopher L Corless, Xin Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)Michael C Heinrich, Grant A McArthur, George D Demetri, et al.
Pageof 29